Optimized treatment reduces the mortality risk associated with chronic heart failure, leading to improvements in both ...

Migraine is recognized globally as the seventh most disabling condition across all diseases, accounting for approximately 2.9 ...

Migraine is far more than “just a headache.” It’s a complex neurological disorder that affects nearly one in seven people ...

Beta Drugs Ltd (NSE:BETA) reported a 24.14% increase in consolidated revenue, reaching INR 362 crores. The company successfully launched 5 to 6 new molecules and concluded a significant audit from ...

Taste, pain, or response to stress—nearly all essential functions in the human body are regulated by molecular switches ...

Discover effective strategies to lower resistant high blood pressure, from medication evaluation and dietary changes to ...

With rising global temperatures and increasingly frequent heatwaves, outdoor workers have become one of the most vulnerable ...

As the boomers age, many will have medication issues. That can be compounded by the number of drugs they take, both ...

The dose of the first- or second-generation β blocker that the patient is receiving is an important consideration for the switching regimen chosen. The major factors to be kept in mind when ...

The European Medicines Agency (EMA) has designated allopurinol as the first orphan drug for the treatment of Marfan syndrome, ...

After a heart attack, doctors often prescribe beta blockers to help prevent further heart issues. These medications are ...